UPS steps up push into European pharma logistics
This article was originally published in Scrip
UPS, one of the world's largest package delivery services, is preparing to enter the European healthcare market with the construction of a 20,000m2 multi-client distribution centre at its existing logistics campus in Roermond, the Netherlands. When it becomes operational next April, the new facility will provide inventory management, temperature-sensitive storage and quality assurance for the pharmaceutical, biotech and medical device industries.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.